The tweet was deleted by the author.
But we saved everything 🙂.
Privia Health is hiring a Sales Growth Director in Orlando, FL.
The position targets healthcare sales leaders who excel at building relationships, closing complex deals, and driving growth. Interested candidates are encouraged to apply through the company link provided.
PRVA is trading at $23.92, above the MA-20 ($22.26), MA-50 ($23.08), and MA-200 ($23.30), reflecting bullish confirmation across short-, medium-, and longer-term trends. The Ichimoku Kijun at $22.22 sits below the current price and thus acts as immediate support; nearby support levels are clustered at the MA-50 ($23.08) and MA-200 ($23.30), while near-term resistance is at the MA-5 ($23.41) and key resistance at the previous week’s high ($23.83).
Momentum signals on D1 are mixed: MACD and ADX both indicate neutral momentum, while RSI (60.20) remains in bullish territory. Stoch RSI and CCI show strong overbought conditions, and BBP at 0.98 suggests intraday buyers are dominating. The Awesome Oscillator is supportive of the upward trend. PRVA has risen $0.25 (1.06%) over the past week, trading up from a previous weekly close of $23.67. The current price stands at the very top of the weekly range and weekly volatility is 3.20%. This reflects a strong upward push with prices consolidating near short-term resistance.
For the coming week, the expected price range is $23.30–$24.10, consistent with the current upward bias and well positioned between the 52-week low of $18.77 and high of $26.51. The probability of further price gains is high (more than 80%), while the likelihood of a decline is very low. Baseline scenario: PRVA stays rangebound within $23.30–$24.10. Bullish scenario: a breakout above $24.10 could open room toward the yearly high. Bearish scenario: a pullback below $23.30 would expose $23.08–$22.60 as support, but this outcome appears less likely at present.
Previously it was reported that Privia Health was maintaining strong bullish momentum, with technical indicators supporting further potential gains. The current analysis revisits this outlook, urging investors to closely watch for shifts in volatility and emerging support or resistance zones that could shape the next move for PRVA.